Destination Net Zero

The race to Net Zero is well underway, but how fast are companies really progressing? Criticaleye Partner Accenture’s Destination Net Zero report sheds light on this question. Drawing on data from the world’s 2,000 largest companies by revenue (G2000), the report reveals that although progress is being made, the current pace remains insufficient to meet global climate goals.
 
 
Key takeways include:
  • Since 2016, 55 percent of G2000 companies have reduced their operational emissions (Scope 1 and 2), up 3 percent since 2023
  • 77 percent have lowered their emissions intensity (emissions per unit of revenue), an improvement of 2 percent since 2023.
  • 30 percent are now deploying 15 or more decarbonisation levers — a critical threshold for meaningful progress towards net zero.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Inside the Take-private at Pr...

After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...

Inspiring Leaders Podcast: Le...

Rob Hornby, Co-CEO of AlixPartners and Rita Clifton CBE, Portfolio Chair and Non-Executive Director (including Deputy Chair of the John Lewis Partnership, Chair of Simplyhealth, Chair of the international sustainability...

Inspiring Leaders Podcast: De...

Lucinda Charles-Jones, Non-executive Director & Chair or RemCo for Virgin Money and Rank Group (plus a Criticaleye Board Mentor) and Jim Devine, Group HRD, Spirax Group speak to us about some of the findings of our ...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 484




Palo Alto Networks Lightsource bp Accenture London Stock Exchange Group NATS Drax Group plc Workday NatWest Group Salesforce Rolls-Royce IBM Consulting Google Worldpay Legal & General E.ON UK Aldermore Group FTSE Women Leaders Review Concentrix Hitachi Solutions Eightfold AI British Land GlaxoSmithKline plc AlixPartners